APA

Pang L. Y., Argyle S. A., Kamida A., Morrison K. O. & Argyle D. J. (20151021). The long-acting COX-2 inhibitor mavacoxib (Trocoxil™) has anti-proliferative and pro-apoptotic effects on canine cancer cell lines and cancer stem cells in vitro. : BMC veterinary research.

Chicago

Pang Lisa Y, Argyle Sally A, Kamida Ayako, Morrison Katherine O'Neill and Argyle David J. 20151021. The long-acting COX-2 inhibitor mavacoxib (Trocoxil™) has anti-proliferative and pro-apoptotic effects on canine cancer cell lines and cancer stem cells in vitro. : BMC veterinary research.

Harvard

Pang L. Y., Argyle S. A., Kamida A., Morrison K. O. and Argyle D. J. (20151021). The long-acting COX-2 inhibitor mavacoxib (Trocoxil™) has anti-proliferative and pro-apoptotic effects on canine cancer cell lines and cancer stem cells in vitro. : BMC veterinary research.

MLA

Pang Lisa Y, Argyle Sally A, Kamida Ayako, Morrison Katherine O'Neill and Argyle David J. The long-acting COX-2 inhibitor mavacoxib (Trocoxil™) has anti-proliferative and pro-apoptotic effects on canine cancer cell lines and cancer stem cells in vitro. : BMC veterinary research. 20151021.